Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Aytu Biopharma (AYTU) Current Deferred Tax Assets: 2015

Aytu Biopharma's Current Deferred Tax Assets was N/A to $94,211 in Q3 2015 from the same period last year, while for Sep 2015 it was $94,211, marking a year-over-year change of. This contributed to the annual value of $41,427 for FY2015, which is 29.46% up from last year.
As of Q3 2015, Aytu Biopharma's Current Deferred Tax Assets stood at $94,211, which was up 127.41% from $41,427 recorded in Q2 2015.
Aytu Biopharma's 5-year Current Deferred Tax Assets high stood at $94,211 for Q3 2015, and its period low was $41,427 during Q2 2015.
Moreover, its 1-year median value for Current Deferred Tax Assets was $67,819 (2015), whereas its average is $67,819.